{"archive_url":"http://www.ebi.ac.uk/ena/next_data/view/ERX297410","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me1","EXPERIMENT_ID":"ERX297410","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["3x 10 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me1"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["#BP140"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 µl"],"EXPERIMENT_TYPE":["Histone H3K4me1"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["0,2 µg"],"CHIP_ANTIBODY_LOT":["A1863-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 µl"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"ENA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"1.1G","NAME":"BP_U-266_c01.H3K4me1.wiggler.20130819.bw","FILE_TYPE":"CS_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me1.wiggler.20130819.bw","PROTOCOL_DOC":"chip_seq","MD5":"0cb79aa6e9d3f18f73f10634fcc7cb90"},{"FORMAT":"bigBed","SIZE":"1.4M","NAME":"BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.bb","FILE_TYPE":"CS_MACS_TRACK_BROAD_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.bb","PROTOCOL_DOC":"chip_seq","MD5":"e3d77ce6fd55c764d56a5a82b428129a"},{"FORMAT":"BED","SIZE":"2.1M","NAME":"BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.bed.gz","FILE_TYPE":"CS_BROAD_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.bed.gz","PROTOCOL_DOC":"chip_seq","MD5":"c6842f0dd640665c8be1e5dd6dbc5551"},{"FORMAT":"Text","SIZE":"2.4M","NAME":"BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.xls.gz","FILE_TYPE":"CS_BROAD_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/next_data/homo_sapiens/Cell_Line/U-266/Multiple_myeloma/ChIP-Seq/NCMLS/BP_U-266_c01.H3K4me1.ppqt_macs2_broad_v2.20130819.xls.gz","PROTOCOL_DOC":"chip_seq","MD5":"435c5831b9d38b3e171f03fff838bb29"}],"sample":{"SAMPLE_DESC_2":"U-266","SAMPLE_DESC_1":"Cell Line","sample_name":"U-266_c01","SAMPLE_DESC_3":"Multiple myeloma","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"MOLECULE":["genomic DNA"],"DISEASE":["Multiple myeloma"],"BIOMATERIAL_PROVIDER":["DSMZ"],"BATCH":["NA"],"LINEAGE":["NA"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C0026764","label":"C0026764"}],"SAMPLE_ONTOLOGY_URI":[{"url":"http://purl.obolibrary.org/obo/CLO_0009457","label":"CLO_0009457"}],"PASSAGE":["NA"],"SEX":["Male"],"DIFFERENTIATION_STAGE":["Plasma cell"],"MEDIUM":["RPMI 1640 + 20%FBS + 1% Glutamine"],"LINE":["U-266"]},"SAMPLE_ID":"ERS333898"}}